Status:
NOT_YET_RECRUITING
The Application of the PDCA Management Model in Improving the Diagnostic Accuracy of AIG
Lead Sponsor:
Ningbo No. 1 Hospital
Conditions:
Autoimmune Gastritis
Eligibility:
All Genders
Brief Summary
Autoimmune gastritis is currently relatively rare in China due to its insidious onset, diverse clinical manifestations involving multiple systems such as digestive, hematological, and nervous systems,...
Eligibility Criteria
Inclusion
- Endoscopy center gastroenterologists in our hospital in 2024
Exclusion
- Doctors who withdrew from the PDCA management midway and stopped undergoing gastroscopy.
Key Trial Info
Start Date :
August 15 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT06557252
Start Date
August 15 2024
End Date
December 31 2024
Last Update
August 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ningbo first hospital
Ningbo, Zhejiang, China, 315000